Registry and Biorepository for the Study of Inflammatory Bowel Diseases in Central Texas
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- Number of patients with inflammatory bowel disease
研究概览
简要总结
This is a prospective, non-interventional registry and biorepository for patients with IBD. Longitudinal follow-up data is collected from both patients and their treating gastroenterologist during routine clinical encounters. The biorepository will consist of prospective collection of blood samples, tissue samples, and fecal samples for research purposes, while the participants are undergoing a clinically-indicated procedure (i.e. venipuncture for routine tests, IV catheter placement, and/or endoscopy). Participants may choose to provide any or all of the aforementioned information and/or samples.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female, age 18 years or older
- •Willing and able to provide written consent for participation in the registry and biorepository
- •Patients with known or suspected inflammatory bowel disease
排除标准
- •Patient is unable to comprehend and/or cooperate with study activities
- •Patient is too ill to provide consent
- •Coagulopathy that precludes safe biopsy of the bowel
- •Comorbidity that precludes safe participation in endoscopic procedures
结局指标
主要结局
Number of patients with inflammatory bowel disease
时间窗: 10 YEARS
Number of patients with Crohns, ulcerative colitis, and IBD undetermined
次要结局
未报告次要终点
研究者
Linda Anne Feagins, MD
Associate Professor of Medicine
University of Texas at Austin